logo
welcome
Reuters

Reuters

US FDA approves Adaptimmune's gene therapy for rare type of cancer

Reuters
Summary
Nutrition label

79% Informative

Adaptimmune 's first -of-its-kind gene therapy approved to treat a rare type of cancer in the soft tissues.

Synovial sarcoma typically affects young men and impacts about 1,000 people in the United States each year .

The company said the treatment would launch at a list price of $ 727,000 .

VR Score

88

Informative language

93

Neutral language

61

Article tone

formal

Language

English

Language complexity

57

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links